Labetalol Infusion Half-Life
The elimination half-life of intravenous labetalol is approximately 5.5 hours in adults.
Pharmacokinetic Profile
According to the FDA drug label, following intravenous infusion, labetalol has an elimination half-life of about 5.5 hours with a total body clearance of approximately 33 mL/min/kg 1. This is the most authoritative source for this pharmacokinetic parameter.
Key Pharmacokinetic Details:
- Half-life after IV administration: ~5.5 hours 1
- Half-life after oral administration: 6-8 hours 1
- Total body clearance: 33 mL/min/kg 1
- Protein binding: Approximately 50% 1
- Volume of distribution: Extensive (mean 9.41 L/kg) 2
Clinical Implications
The relatively long half-life has important clinical consequences:
In acute aortic dissection, the ESC guidelines note that labetalol's long half-life is a disadvantage because it "prohibits immediate correction of BP in case of hypotension" 3. This makes ultra-short acting agents like esmolol (half-life ~9 minutes) preferable when rapid titration is needed.
Blood pressure effects persist: Following discontinuation of IV labetalol, blood pressure rises gradually and approaches pretreatment baseline values within an average of 16-18 hours in most patients 1. This prolonged effect reflects the drug's elimination kinetics.
Important Caveats
- Hepatic impairment: The elimination half-life is not altered in hepatic dysfunction, but bioavailability increases due to decreased first-pass metabolism 1
- Renal impairment: The elimination half-life remains unchanged 1
- Not dialyzable: Neither hemodialysis nor peritoneal dialysis removes significant amounts (<1%) of labetalol 1
The 5.5-hour half-life means steady-state levels are not reached during typical short-term infusions, which is why the FDA label recommends continuing infusion until satisfactory response is obtained, then transitioning to oral therapy 1.